全文获取类型
收费全文 | 4369篇 |
免费 | 261篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 220篇 |
妇产科学 | 68篇 |
基础医学 | 323篇 |
口腔科学 | 77篇 |
临床医学 | 321篇 |
内科学 | 1240篇 |
皮肤病学 | 57篇 |
神经病学 | 239篇 |
特种医学 | 154篇 |
外科学 | 842篇 |
综合类 | 88篇 |
一般理论 | 2篇 |
预防医学 | 147篇 |
眼科学 | 106篇 |
药学 | 271篇 |
中国医学 | 16篇 |
肿瘤学 | 425篇 |
出版年
2024年 | 1篇 |
2023年 | 48篇 |
2022年 | 38篇 |
2021年 | 162篇 |
2020年 | 111篇 |
2019年 | 164篇 |
2018年 | 187篇 |
2017年 | 115篇 |
2016年 | 156篇 |
2015年 | 131篇 |
2014年 | 232篇 |
2013年 | 265篇 |
2012年 | 405篇 |
2011年 | 399篇 |
2010年 | 249篇 |
2009年 | 201篇 |
2008年 | 323篇 |
2007年 | 337篇 |
2006年 | 240篇 |
2005年 | 231篇 |
2004年 | 201篇 |
2003年 | 148篇 |
2002年 | 126篇 |
2001年 | 20篇 |
2000年 | 15篇 |
1999年 | 18篇 |
1998年 | 20篇 |
1997年 | 12篇 |
1996年 | 19篇 |
1995年 | 17篇 |
1994年 | 10篇 |
1993年 | 11篇 |
1992年 | 6篇 |
1991年 | 5篇 |
1990年 | 7篇 |
1989年 | 6篇 |
1988年 | 3篇 |
1987年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1972年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有4651条查询结果,搜索用时 265 毫秒
1.
Sandeep Kumar Shukla Ajay Kumar Sharma Vanya Gupta M.H. Yashavarddhan 《Journal of tissue viability》2019,28(4):218-222
Wound inflammation is a rapid and highly orchestrated process that significantly impacts the wound healing cascade. Consequent to injury, a series of events set off that include inflammatory, proliferation and maturation phases leading to wound closure and restoration of normal skin integrity. Stimuli causing stress to host immune system or induce inflammatory response include tissue damage and pathogenic microbial infection.Several evidences points towards the positive role of inflammation as it essential to fight against the attack of invading pathogens and to remove dead tissues from the site of injury. Besides its positive role, prolonged inflammation is injurious and may result in deregulated stages of the wound healing which may lead to excessive scarring. Achieving balance in inflammatory cascade is one of the challenging tasks for development of a wound healing drug.This review mainly focuses on the pharmacological control of inflammation by agents which critically balance the inflammatory cascade. However, none of the agent is available in the healthcare market which exclusively plays a role in wound repair. In this review we shall explore different factors or agents affecting inflammation in wound healing. This information might be helpful in designing and development new process, technologies or drugs for better management of wound care. In addition, understanding the effect of inflammation on the outcome of the healing process will serve as a significant milestone in the area of pathological tissue repair. 相似文献
2.
Yanyan Gu Benjamin G. Barwick Mala Shanmugam Craig C. Hofmeister Jonathan Kaufman Ajay Nooka Vikas Gupta Madhav Dhodapkar Lawrence H. Boise Sagar Lonial 《Blood cancer journal》2020,10(12)
Protein homeostasis is critical for maintaining eukaryotic cell function as well as responses to intrinsic and extrinsic stress. The proteasome is a major portion of the proteolytic machinery in mammalian cells and plays an important role in protein homeostasis. Multiple myeloma (MM) is a plasma cell malignancy with high production of immunoglobulins and is especially sensitive to treatments that impact protein catabolism. Therapeutic agents such as proteasome inhibitors have demonstrated significant benefit for myeloma patients in all treatment phases. Here, we demonstrate that the 11S proteasome activator PA28α is upregulated in MM cells and is key for myeloma cell growth and proliferation. PA28α also regulates MM cell sensitivity to proteasome inhibitors. Downregulation of PA28α inhibits both proteasomal load and activity, resulting in a change in protein homeostasis less dependent on the proteasome and leads to cell resistance to proteasome inhibitors. Thus, our findings suggest an important role of PA28α in MM biology, and also provides a new approach for targeting the ubiquitin-proteasome system and ultimately sensitivity to proteasome inhibitors.Subject terms: Myeloma, Translational research 相似文献
3.
4.
5.
Partha Sardar Deepak L. Bhatt Ajay J. Kirtane Kevin F. Kennedy Saurav Chatterjee Jay Giri Peter A. Soukas William B. White Sahil A. Parikh Herbert D. Aronow 《Journal of the American College of Cardiology》2019,73(13):1633-1642
Background
There are conflicting data regarding the relative effectiveness of renal sympathetic denervation (RSD) in patients with hypertension.Objectives
The purpose of this study was to evaluate the blood pressure (BP) response after RSD in sham-controlled randomized trials.Methods
Databases were searched through June 30, 2018. Randomized trials (RCTs) with ≥50 patients comparing catheter-based RSD with a sham control were included. The authors calculated summary treatment estimates as weighted mean differences (WMD) with 95% confidence intervals (CIs) using random-effects meta-analysis.Results
The analysis included 977 patients from 6 trials. The reduction in 24-h ambulatory systolic blood pressure (ASBP) was significantly greater for patients treated with RSD than sham procedure (WMD ?3.65 mm Hg, 95% CI: ?5.33 to ?1.98; p < 0.001). Compared with sham, RSD was also associated with a significant decrease in daytime ASBP (WMD ?4.07 mm Hg, 95% CI: ?6.46 to ?1.68; p < 0.001), office systolic BP (WMD ?5.53 mm Hg, 95% CI: ?8.18 to ?2.87; p < 0.001), 24-h ambulatory diastolic BP (WMD ?1.71 mm Hg, 95% CI: ?3.06 to ?0.35; p = 0.01), daytime ambulatory diastolic BP (WMD ?1.57 mm Hg, 95% CI: ?2.73 to ?0.42; p = 0.008), and office diastolic BP (WMD ?3.37 mm Hg, 95% CI: ?4.86 to ?1.88; p < 0.001). Compared with first-generation trials, a significantly greater reduction in daytime ASBP was observed with RSD in second-generation trials (6.12 mm Hg vs. 2.14 mm Hg; p interaction = 0.04); however, this interaction was not significant for 24-h ASBP (4.85 mm Hg vs. 2.23 mm Hg; p interaction = 0.13).Conclusions
RSD significantly reduced blood pressure compared with sham control. Results of this meta-analysis should inform the design of larger, pivotal trials to evaluate the long-term efficacy and safety of RSD in patients with hypertension. 相似文献6.
7.
8.
Elena Laaf MSc Carina Benstoem Dr. rer. medic. Rolf Rossaint Univ.-Prof. Sebastian Wendt Dr. rer. medic. Christina Fitzner Dipl. stat. Ajay Moza PD Dr. med. Rashad Zayat PD Dr. med. Aileen Hill Dr. med. Daren K. Heyland MD Lutz Schomburg Dr. rer. nat. Andreas Goetzenich MD PD Christian Stoppe MD 《JPEN. Journal of parenteral and enteral nutrition》2022,46(6):1412-1419
9.
10.
Suyash S. Kulkarni Nitin Sudhakar Shetty Kunal B. Gala Mohd Shariq Ashish Gulia Ashwin M. Polnaya Neeraj G. Shetty Amit Kumar Janu Amitkumar Choudhari Ajay Puri 《Journal of vascular and interventional radiology : JVIR》2021,32(4):504-509
PurposeTo evaluate safety and long-term efficacy of radiofrequency (RF) ablation in treatment of chondroblastoma.Materials and MethodsThis retrospective analysis comprised 27 consecutive patients with histopathologically proven chondroblastoma treated by RF ablation. The tumors were located in the proximal humerus (n = 6), proximal tibia (n = 8), proximal femur (n = 6), distal femur (n = 5), acromion process (n = 1), and lunate (n = 1). In 19 patients (70.3%), the tumor was in the weight-bearing area of the bone. Clinical response was assessed by comparing pain scores and functional assessment by Musculoskeletal Tumor Society (MSTS) score before and after ablation. Patients were followed for a minimum of 1 year to rule out complications and recurrence.ResultsTechnical success rate was 100%. Mean pain score before the procedure was 7.34 (range, 7–9); all patients experienced a reduction in pain, with 25 (92.6%) patients reporting complete pain relief at 6 weeks. Mean MSTS score before the procedure was 15.4, whereas mean MSTS score at 6 weeks after the procedure was 28.6, suggesting significant functional improvement (P < .0001). Two patients developed osteonecrosis and collapse of the treated bone. There were no recurrences.ConclusionsPercutaneous RF ablation is a safe and effective option for treating chondroblastoma of the appendicular skeleton. 相似文献